The product name "DOPACONE 100+25+200mg Tablets" suggests a triple-combination medication. Based on standard pharmaceutical formulations in Pakistan and global practice, this combination most likely contains:

✅ Levodopa 100mg

✅ Carbidopa 25mg

✅ Entacapone 200mg

This is a well-established fixed-dose combination used in the management of Parkinson’s disease, designed to enhance dopamine availability in the brain while minimizing peripheral side effects.

📌 Note: The brand name "DOPACONE" aligns with this composition—“DOPA” refers to levodopa, and “CONE” suggests entacapone, a COMT inhibitor.

Product Full Description (English):

Product Information:

DOPACONE 100+25+200mg Tablets combine three agents for optimized Parkinson’s therapy:

1. Levodopa 100mg: Dopamine precursor that crosses the blood-brain barrier.
2. Carbidopa 25mg: Peripheral decarboxylase inhibitor that prevents levodopa breakdown outside the brain, reducing nausea and allowing lower levodopa doses.
3. Entacapone 200mg: Catechol-O-methyltransferase (COMT) inhibitor that prolongs levodopa’s effect by blocking its metabolism in the periphery.

This triple combination increases "on" time, reduces motor fluctuations ("wearing-off"), and improves symptom control in mid-to-advanced Parkinson’s disease.

Uses of (DOPACONE 100+25+200MG TABLETS):

1. Adjunctive treatment of Parkinson’s disease in patients experiencing end-of-dose "wearing-off"
2. Patients already stabilized on levodopa/carbidopa who require enhanced response duration
3. Reduction of "off" periods and improvement in motor function

Key Benefits of (DOPACONE 100+25+200MG TABLETS):

1. Extends duration of levodopa effect by 1–2 hours per dose
2. Reduces daily "off" time by up to 1–2 hours on average
3. Maintains or improves motor function without increasing total levodopa dose
4. Convenient single-tablet replacement for separate levodopa/carbidopa + entacapone

How To Use (DOPACONE 100+25+200MG TABLETS):

Take exactly as prescribed—typically one tablet per dose, matching your previous levodopa/carbidopa regimen.

1. Administer with or without food, but avoid high-protein meals near dosing time (may impair absorption).
2. Do not crush or chew.
3. Dose frequency usually matches prior levodopa schedule (e.g., 3–6 times daily).
4. Do not substitute 1:1 with standard levodopa/carbidopa—requires medical supervision during transition.

When Not to Use (DOPACONE 100+25+200MG TABLETS):

Do not use if you have:

1. Hypersensitivity to levodopa, carbidopa, entacapone, or any excipients
2. Narrow-angle glaucoma
3. History of melanoma or undiagnosed skin lesions (levodopa may activate malignant melanoma)
4. Concurrent use of non-selective MAO inhibitors (e.g., phenelzine, tranylcypromine)—wait at least 2 weeks after discontinuation
5. Severe hepatic impairment (entacapone is metabolized in the liver)

Side Effects of (DOPACONE 100+25+200MG TABLETS):

Common: Dyskinesia (involuntary movements), nausea, diarrhea, urine discoloration (harmless orange/brown), dizziness, headache.

Serious (rare):

1. Worsening Parkinsonism or hallucinations (especially in elderly)
2. Rhabdomyolysis (muscle pain/weakness with dark urine)
3. Hepatotoxicity (entacapone—monitor LFTs if symptomatic)
4. Orthostatic hypotension, confusion, or impulse control disorders (gambling, hypersexuality)
5. Discontinue and seek medical help if severe psychiatric or motor symptoms occur.

Dosage: (DOPACONE 100+25+200MG TABLETS):

1. Replaces one tablet of levodopa 100mg + carbidopa 25mg plus entacapone 200mg
2. Typical dosing: 3–6 times daily, aligned with prior levodopa schedule
3. Maximum entacapone: 1,600mg/day (i.e., ≤8 tablets)
4. Adjust under neurologist supervision

Who It’s For (DOPACONE 100+25+200MG TABLETS):

Adults with Parkinson’s disease experiencing motor fluctuations on levodopa/carbidopa therapy. Not for early-stage Parkinson’s or patients not already on levodopa.

Warnings & Precautions:

1. May cause sudden sleep onset—avoid driving or operating machinery
2. Monitor for impulse control disorders and psychiatric symptoms
3. Entacapone may cause diarrhea (can be severe)—discontinue if persistent
4. Urine may turn orange, red, or brown—harmless but may stain clothing
5. Avoid iron supplements within 2 hours of dosing (reduces absorption)

Drug Interactions:

1. MAO inhibitors (non-selective): Risk of hypertensive crisis—contraindicated
2. Antipsychotics (e.g., haloperidol): May reverse anti-Parkinson effects
3. Iron salts: Reduce levodopa absorption—administer 2+ hours apart
4. Dopamine antagonists (metoclopramide, reserpine): Counteract therapeutic effect
5. Always inform your neurologist about all medications.

Additional Information:

Store below 25°C in a dry place, protected from light. Keep out of reach of children. Do not use after the expiration date. Available by prescription only in Pakistan.